Study in Advanced Solid Tumor Patients
NCT07300943
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
CLIO-8221
Sponsor
Callio Therapeutics